VERTEX PHARMACEUTICALS INC

Ticker: VRTX CUSIP: 92532F100 Class: EQTY

CHELSEA COUNSEL CO's Holding History (CIK: 0001276755)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 150 Value ($000) $68 Avg Close $431.03 Range $392.50 - $464.44
Q3 2025
Shares 150 Value ($000) $59 Avg Close $417.92 Range $362.50 - $484.56
Q2 2025
Shares 150 Value ($000) $67 Avg Close $460.83 Range $416.60 - $510.77
Q1 2025
Shares 150 Value ($000) $73 Avg Close $466.00 Range $397.25 - $519.68
Q4 2024
Shares 150 Value ($000) $60 Avg Close $463.53 Range $377.85 - $519.88
Q3 2024
Shares 150 Value ($000) $70 Avg Close $480.37 Range $456.07 - $510.64
Q2 2024
Shares 150 Value ($000) $70 Avg Close $434.05 Range $391.01 - $486.43
Q1 2015
Shares 2,300 Value ($000) $271 Avg Close $119.81 Range $103.75 - $136.33
Q4 2014
Shares 2,300 Value ($000) $273 Avg Close $112.63 Range $96.43 - $124.35